Data / Form D filings / Carmot Therapeutics Inc.
Carmot Therapeutics Inc.: Form D filings
Carmot Therapeutics Inc., a biotechnology company in Berkeley, CA, filed 6 Form D notices with the SEC between 2010 and 2023. The latest, on June 6, 2023, reports $150 million sold of a $150 million offering to 25 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 740 HEINZ AVENUE, Berkeley, CA, 94710
- Phone
- (888) 402-4674
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1490109
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 6, 2023 | New notice | $149,999,802 | $149,999,802 | 25 | May 24, 2023 | sec.gov | |
| Aug 8, 2022 | New notice | $160,671,809 | $160,671,809 | 15 | Jul 25, 2022 | sec.gov | |
| Oct 1, 2020 | New notice | $46,882,157 | $26,282,207 | $20,599,950 | 6 | Sep 17, 2020 | sec.gov |
| Aug 25, 2017 | New notice | $15,374,764 | $10,795,943 | $4,578,821 | 4 | Aug 11, 2017 | sec.gov |
| Jul 17, 2012 | New notice | $1,200,317 | $500,159 | $700,158 | 2 | Jun 28, 2012 | sec.gov |
| Apr 23, 2010 | New notice | $1,549,999 | $1,549,999 | 2 | Apr 7, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Anne K. Phillips, M.D. | Director | |
| Tim K. Kutzkey | Director | |
| Peter K. Svennilson | Director | |
| Aetna Wun K. Trombley | Director | |
| Timothy K. Garnett | Director | |
| Stig K. Hansen, Ph.D. | Director | |
| Heather K. Turner | Executive Officer, Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Jun 5, 2023 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Carmot Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.